Vizgen
vizgen.com
Actively hiring
Laboratory Equipment
Bioinformatics
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$361.9M
10 rounds on record
Latest round
$47.8M
Venture round · Dec 2025 · 8 mo ago
Team
26
US Form 5500 (plan participants) · Dec 2025 · -73% in a year
Backers
1
ARCH Venture Partners
The money's age
Fresh money
8 months since the last round · not hiring
Momentum
20/100
fresh money
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2025 | $47.8M | — | SEC Form D |
| Debt Financing | Oct 2025 | $3.5M | — | SEC Form D |
| Venture round | Oct 2024 | $107.6M | — | SEC Form D |
| Venture round | Jul 2024 | $3.3M | — | SEC Form D |
| Venture round | Apr 2022 | $85.2M | — | SEC Form D |
| Venture round | Mar 2021 | $37M | — | SEC Form D |
| Venture round | Oct 2019 | $14M | — | SEC Form D |
| Venture round | Jun 2019 | $26.5M | — | SEC Form D |
| Venture round | Jul 2017 | $20.2M | — | SEC Form D |
| Venture round | Jul 2017 | $20.2M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Ultivue, Inc. | sec |
Founders and leadersfrom filings, registers and the company's site
Michael NatanExecutive Officer, DirectorSEC Form D
Dr. Peidong WangExecutive Officer, DirectorSEC Form D
Dr. Philip GardellaExecutive OfficerSEC Form D
Dr. Jiang HeExecutive OfficerSEC Form D
Philip GardellaExecutive OfficerSEC Form D
Terry LoDirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
ARCH Venture Partners Similar startupsby what they do, their industry and backers
The Cellanome live-cell, multimodal platform links molecular, functional, and temporal data from the same cells over time. Our proprietary…
RareCyte, Inc. is a Seattle-based precision biology company developing advanced platforms and services for spatial biology and liquid…
Spatial proteomics from H&E. Lattice predicts spatially resolved protein-marker maps from routine H&E, delivered as virtual mIF channels.
Panome Bio delivers advanced multi-omics services including Next-Generation Metabolomics, Discovery Proteomics, Transcriptomics, and…
Don't settle for 2D spatial biology. Discover the power of automated 3D spatial multiomics with Stellaromics Pyxa platform.
insitro applies machine learning to human genetic and cellular data for drug discovery. Its laboratory generates large datasets…
People
Michael Natan
Executive Officer, Director
Dr. Peidong Wang
Executive Officer, Director
Dr. Philip Gardella
Executive Officer
Dr. Jiang He
Executive Officer
Philip Gardella
Executive Officer
Terry Lo
Director
Robert Carson
Executive Officer, Director
Seth Benson
Executive Officer
Simona Levi
Executive Officer
Chris Guiffre
Executive Officer
Andrew Stevenson
Director
Peng Yin
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Cambridge
United States
HQ
Waltham
United States
Regional office
About Vizgen
Financials
Total raised
$365.4M
Latest round
Venture - Series Unknown
Funding rounds
10
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $47.8M | Details |
| Debt Financing | 2025 | $3.5M | Details |
| Venture - Series Unknown | 2024 | $107.6M | Details |
| Venture - Series Unknown | 2024 | $3.3M | Details |
| Venture - Series Unknown | 2022 | $85.2M | Details |
| Venture - Series Unknown | 2021 | $37M | Details |
| Venture - Series Unknown | 2019 | $14M | Details |
| Venture - Series Unknown | 2019 | $26.5M | Details |
| Venture - Series Unknown | 2017 | $20.2M | Details |
| Venture - Series Unknown | 2017 | $20.2M | Details |